Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.
暂无分享,去创建一个
S. Emerson | R. Purcell | J. Bukh | F. Chisari | X. Forns | S. Govindarajan | R. Thimme | R. Thimme
[1] S. Emerson,et al. Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV , 2000, Hepatology.
[2] J. Bukh,et al. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface. , 2000, Virology.
[3] M. Cucchiarini,et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. , 2000, The Journal of infectious diseases.
[4] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[5] H J Alter,et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.
[6] J. Jansson,et al. Growth hormone induces CCAAT/enhancer binding protein α (C/EBPα) in cultured rat hepatocytes , 2000 .
[7] C. Rice,et al. Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo , 2000, Journal of Virology.
[8] R. Purcell,et al. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. , 1999, Trends in microbiology.
[9] R H Purcell,et al. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. , 1999, Virology.
[10] J. Dubuisson,et al. Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 , 1999, Journal of Virology.
[11] A. Nicosia,et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. , 1999, Journal of immunology.
[12] M. Shapiro,et al. Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.
[13] P Parham,et al. Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.
[14] O. Laeyendecker,et al. Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.
[15] M. Yanagi,et al. In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Houghton,et al. Binding of hepatitis C virus to CD81. , 1998, Science.
[17] Y. Liaw,et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. , 1998, Gastroenterology.
[18] J. Bukh,et al. Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. , 1998, The Journal of infectious diseases.
[19] Anna Tramontano,et al. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants , 1998, The EMBO journal.
[20] Jane McAllister,et al. Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort , 1998, Journal of Virology.
[21] M. Yanagi,et al. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. , 1998, Virology.
[22] A. Sette,et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.
[23] M. Yanagi,et al. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Rice,et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. , 1997, Science.
[25] H. Yagita,et al. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope , 1997, European journal of immunology.
[26] A. Zibert,et al. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus , 1997, Journal of virology.
[27] A. Zibert,et al. Early antibody response against hypervariable region 1 is associated with acute self‐limiting infections of hepatitis C virus , 1997, Hepatology.
[28] S. Jacobson,et al. Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response. , 1997, The Journal of infectious diseases.
[29] E. E. Kritzinger,et al. Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997? , 1997, Eye.
[30] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Purcell,et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.
[32] M. Massari,et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.
[33] M. Houghton,et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Santantonio,et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.
[35] E. Schreier,et al. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. , 1995, Virology.
[36] F. Chisari,et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.
[37] R. Purcell,et al. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.
[38] M. Houghton,et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. , 1993, Journal of immunology.
[39] J. Sodroski,et al. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions , 1993, Journal of virology.
[40] M. Sakamoto,et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. , 1993, Virology.
[41] N. Kato,et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.
[42] Giorgio,et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Purcell,et al. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] N. Kato,et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.
[45] Matthew J. Brauer,et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.